GPT Healthcare Ltd (NSE: GPTHEALTH) Q3 2026 Earnings Call dated Feb. 03, 2026
Corporate Participants:
Anurag Tantia — Executive Director
Atul Tantia — Group Chief Financial Officer
Analysts:
Unidentified Participant
Sejal Bhattar — Analyst
Sukrut Patil — Analyst
Sunil Jain — Analyst
Abhishek Maheshwari — Analyst
Siddhant Kanodia — Analyst
Richa Chaudhary — Analyst
Arpit Tapadia — Analyst
Rucheeta Kadge — Analyst
Anuj Kashyap — Analyst
Presentation:
operator
Ladies and gentlemen, good day and welcome to GPT Healthcare Limited Q3FY26 earnings conference call hosted by MUFJ in time. As a reminder, all participant lines will be in the listen only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing Star then zero on your touchtone phone. Please note that this conference has been recorded and now hand the conference over to Ms. Sejal Bhattar from Mung in time. Thank you. And over to you ma’.
Sejal Bhattar — Analyst
Am. Thank you. Welcome to Q3 and 9 month X526 earnings call of GPT Healthcare Limited. Today on this call we have with us Mr. Atul Tantia Group CFO, Mr. Anurag Tantia, Executive Director and Mrs. K.T. tantia, CFO. Before we proceed the call, I would like to give a small disclaimer that this conference may contain certain forward looking statements which are based on beliefs, opinions and expectations of the company as on date. These statements are not guaranteed of future performance and involve risk and uncertainty which are difficult to predict. A detailed disclaimer has been given in the company’s investor presentation which is uploaded on Stock Exchange.
Now I would like to hand over the conference to the management for the opening remarks. Over to you sir.
Anurag Tantia — Executive Director
Good morning everyone. Thank you for joining us today for GPT Healthcare Limited’s Q3 and nine months fiscal ending FY26 earnings call. Let me begin with a brief overview of the industry outlook. India’s healthcare sector is at a decisive inflection point offering a strong Runway for scale quality led growth. With the industry’s estimated value at 638 billion in 2025 along with a healthy expected CAGR growth of 17.5 to 22.5% driven by favorable demographics, rising health awareness, a growing burden of chronic and lifestyle diseases and improved access to organized care. Beyond tier one cities into urban and semi urban markets, India has developed a strong healthcare infrastructure with almost 780 medical colleges and close to 14 lakh doctors.
And with the continued government focus, the same is expected to further improve going forward. In the Budget 2026 Honorable Finance Minister has allocated almost 1.6 lakh crore health budget which is a 9% increase from current financial year. Demand catalysts are firmly in place with medical tourism rebounding in India supported by superior outcomes, international accreditations and cost competitiveness. While the public platforms are expanding affordability and access to through Ayushman cards, a rapidly scaling digital backbone of Abha IDs and 33,000 plus empanelled hospitals strengthening tertiary Care Reach Our network of hospitals is very well positioned, favorably gained from the above with our focused neighborhood tertiary care network of affordable healthcare facilities.
Now let us talk about the business highlights and financial highlights starting with our overall financial performance for nine months ending FY26. EBITDA for the period stood at 65.1 crore with a margin of 18.58% reflecting a stable operating performance and continued focus on cost discipline. Profit after tax was rupees 27.6 crores translating into a packed margin of 7.89%. Revenue from operations came in at 350.5 crores registering a healthy year on year growth of 12.12% and a 16.81% growth compared to the same quarter last year. These have been driven by improving occupancies, better case mix and higher throughput across hospitals.
On the operational front, the average revenue per occupied bed for nine months FY26 stood at 38,797 supported by a focus on specialized procedures and mid to minimum premium peer mix. Overall bed occupancy improved to 55% excluding the newly commissioned Raipur facility reflecting steady ramp up across hospitals and continued traction mature facilities. Including the Raipur facility, The occupancy was 45%. The overall average length of stay improved to 3.48 compared to 3.5 for the previous fiscal. Approximately 90% of our business continues to come from cash and insurance patients reflecting the strength of our tertiary care model coming to the hospital.
Wise Performance the Salt Lake Hospital continued to deliver strong performance during the quarter. The hospital witnessed an improvement in occupancy levels from 58% to 63% during the nine months period. This was supported by a sustained increase in RPOB alongside a favorable case mix. A key highlight remains the robot enabled surgical program with approximately 750 plus number of procedures undertaken till date. With a growing number of complex and minimally invasive procedures being performed, the Salt Lake Hospital retains its position as a high end surgical center. The Agartala Hospital, with a capacity of 205 beds is the only corporate tertiary care hospital in the Sierra Tripura playing a critical role in addressing advanced healthcare needs in the region.
During the period the hospital witnessed an occupancy growth from 47 to 52% and an RPOC growth of almost 9% YoY. With the start of comprehensive oncology services in this hospital, we expect to increase our scope of services to the people of Tripura and eastern Bangladesh. The Dumnam Hospital recorded a marginal increase in occupancy levels, however. However, the occupancy rate remained north of 65% and well supported by stable demand from its densely populated catchment area. The RPOP increased from 40,880 to 42,396 during the period. We are happy to report the starting of the Department of Cardiac and Thoracic Surgery in this hospital in line with our commitment to increase the number of operated departments.
The Havra Hospital, located in close proximity to densely populated Hawa station area is one of its kind facility in the five kilometer areas. This hospital has reported improved occupancy in RPAP during the quarter in line with the other facilities. Driven by increasing patient volumes and expanding clinical offerings. The hospital is successfully managing and growing its robotic knees replacement surgery segment which has been well received and is expected to contribute meaningfully to the revenue growth and case mix going forward. ILS Hospital Raipur continued its ramp up trajectory during the quarter. The hospital has expanded its clinical capabilities with the initiation of advanced treatment and surgical procedures and we are pleased to share that the facility is on track to achieve EBITDA break even in the next six to eight months well within the targeted time frame.
This milestone reflects improving occupancies, growing acceptance and new duty, geography and disciplined execution. The Raipur facility is equipped with some of the most advanced equipment and has facilities for chemotherapy and oncology surgeries and fully operational. The Jamshedpur Hospital which is upcoming remains firmly on track following the signing of the MOU. The project work on the planned 150 bed facility is progressing as per schedule and we continue to work towards commissioning it within the guided timeline. This hospital will further strengthen our presence in the underserved regions supporting our long term growth strategy. During the quarter we continue to invest in technology LED delivery care delivery including robotic surgeries, advanced diagnostics and specialized surgery procedures across hospitals.
Our focus remains on enhancing clinical outcomes through modern medical infrastructure, skilled clinicians and patient centric processors. As we move forward, we remain committed to our vision of building a thousand bedded hospital chain targeted by 2027, expanding access to quality tertiary health care and strengthening our presence across eastern India. This strategy is anchored in scalable growth, clinical excellence and disciplined financial execution and continues to guide our long term direction. Thank you for your attention. With this I conclude my opening remarks and would now request the moderator to open the floor for questions. I look forward to addressing your queries regarding our performance and future outlook.
Thank you.
Questions and Answers:
operator
Thank you Very much. We will now begin with the question and answer session. Anyone who wishes to ask the question may press star and one on your touchstone telephone. If you wish to remove yourself from the question queue, you may press star and two Participants are requested to use handsets while asking questions. Ladies and gentlemen, we will wait for a moment while the question queue assemble. The first question comes from the line of Sutri departing from ISI Twin trade. Please go ahead.
Sukrut Patil
Good morning to the team. My name is Sukrut Patil. I have two questions. My first question is looking at GPT healthcare, core, OTC and prescription brand. How does management decide where to increase focus and where to stay cautious as market conditions evolve? As you track the business through the year, what changes in consumer demand, doctor engagement or distribution productivity typically signal the need to adjust these settings. Just want to understand your view on this. Thank you. That’s my first question. I’ll ask my second question after this.
Anurag Tantia
So we constantly track the productivity across our clinical specialties and there is a constant metrics which includes the length of stay, the RPUB of a particular department, the number of patients. These are matrices which are strongly tracked by the management team and accordingly we add the number of doctors available or the productivity increase. We monitor the same throughout the year with this in mind. For example, we started cardiac surgeries in the Gamdam hospital this financial year in the past two months and we’ve already increased significant seen productivity numbers of almost 15 surgeries in the past one month.
So these are metrics which are constantly monitored to end up giving us feedback as to what departments can end up starting in which hospital. Thank you.
Sukrut Patil
A similar question to Mr. Atul beyond the margins discussed, what are the key internal indicators you track closely such as trade, spend, channel mix or working capital trend to assess whether profitability and cash flow are progressing as expected before these trends reflect on your on the balance sheet.
Atul Tantia
So we do track things like ROE and ROCE as well. Also we do track cash to EBITDA conversion because we feel that that is a very important metrics to track. This also enables us to check our debtor levels, trade payables, etc. So all this is something channel financing and all that we don’t do as such. So we track roe, ROC cash flow to EBITDA conversion and data levels. Those are three afford metrics we do track in terms of the balance sheet.
Sukrut Patil
Thank you and best of luck for the next quarter.
operator
Thank you. A request to all participants, please restrict your questions to two per participant. For more questions, please rejoin the Queue. The next question comes from the line of Sunil Jain from Nirmal Bank. Please go ahead.
Sunil Jain
Yeah, thanks for taking my questions. And my question relate to Raipur and damn hospital. So Raipur, can you specify how much is the EBITDA loss in this quarter?
Anurag Tantia
So the ripur EBITDA loss is around 2.5 crores in this quarter.
Sunil Jain
Okay.
Anurag Tantia
And this has considerably reduced from the previous quarter.
Sunil Jain
What was it? Sir?
Anurag Tantia
We are expecting it to go further down in the next few months. Overall, overall the EBITDA loss is around 10 crores of which around 2 crores has been in the previous quarter and the previous HY had 8 crores.
Sunil Jain
Okay, and you expect it to break even in another two to three quarters?
Anurag Tantia
We expect it to break even, yes. In the next six months on a monthly basis.
Sunil Jain
Yeah, yeah. Okay. And sir, second question, it will relate to Dum Dum here. If I see your deck, the utilization has come down in this, apart from this other hospital has done comparatively well and the revenue growth is double digit in most of the hospital. But this is lacking. So any indication why it is so and how you expect it to improve? And what is the AOL in this particular hospital?
Anurag Tantia
So for the Dum Dum hospital we have been in the middle of a restructuring exercise in this hospital. If you see the number of inpatients has increased significantly. The same period last year we had 8,300 patients and in this period we have almost 9,000 patients which is a significant increase of almost 8% in that hospital. This is coming from reduction in dependency on a few departments and activating other departments in this hospital. As I told you, we’ve activated recently activated cardiothoracic surgery in this hospital as well where we’ve already done 15 successful surgeries. We are also activating advanced cardiology procedures and advanced urology procedures in this hospital as well.
So there has been a constant shift and a dedicated focus towards reducing dependence on certain departments in this hospital and activating newer departments at the same time. We’ve been able to reduce the throughput in this hospital. Also our average length of stay has gone down from 4.5 to 4.3 in this hospital. So which is an indication that the strategy which we are planning is working out in this hospital.
Sunil Jain
So this average stay in where you would like to see means in another next 2, 3/4.
Anurag Tantia
Ideally this would should be stable at around the 4 figure. Considering the complex treatments which go on in this hospital, an average length of stay would be of four would be very, very good in this hospital.
Sunil Jain
Okay. And. Then when we can start getting double digit growth? Maybe next year.
Anurag Tantia
Next year we expect this hospital to start giving double digit growth again. We are already on track and we are seeing the traction happen even in the Q3 and Q4.
Sunil Jain
Okay. And sir, other hospital like Hava Agartala. And. Your short leg all have grown in double double digit year on year. So this trend we can expect to continue even in the coming period.
Anurag Tantia
Yes.
Sunil Jain
Great. Thank you very much.
Anurag Tantia
Thank you.
operator
Thank you. The next question comes from the line of Abhishek Maheshwari from Sky Ridge Fund managers. Please go ahead.
Abhishek Maheshwari
Hi. Thank you for taking my question and congratulations on the revenue growth. First question is regarding the other expenses. I’m assuming this is increased because of the R commissioning, but when can we expect the other expenses as a percentage of sales to go back to 40% from this 45% that we have right now?
Anurag Tantia
So yes, you’re right. The other expenses primarily increased on account of the commissioning of the Raipur hospital where a lot of it has gone into promotional expenses for the hospital. We expect that in the next six months to eight months it will come. The ratio should significantly come down.
Abhishek Maheshwari
All right. And any issues you are facing in Agathala because of the Bangladesh issue, so.
Anurag Tantia
We have been able to get past that. We have increased our footprint in Tripura itself. Bangladesh, we have. The number of patients is still not back to what it used to be. So we’ve redirected our marketing and productivity efforts in Tripura and North Tripura, which is giving us results. And with the addition of comprehensive oncology care in our Agartala hospital, we are seeing significant traction where productivity has gone up almost 10% there.
Abhishek Maheshwari
Okay. And with respect to Raipur, I think you’ve already commented on the breakeven part. But just since it’s a new hospital, six months into it, what kind of environment are we seeing there with respect to inpatient and outpatient footfalls and tie up with doctor and surgeon consultants.
Anurag Tantia
So we are doing very well in the Raipur hospital. We’ve already. We are on target with regards to our financial year estimates. In fact, in that hospital, in just under six months, we’ve already started doing renal transplants. We are about to start doing liver transplant in the hospital. We have a very good and dedicated team of clinicians which is well supported by the technology that we have there. And we are seeing good productivity and traction in this hospital.
Abhishek Maheshwari
Got it. And lastly, how is Q4 shaping up? If you can comment on that.
Anurag Tantia
Q4 is as per our estimates at this Point.
Abhishek Maheshwari
All right, I’ll get back to the Q. Thank you sir.
Anurag Tantia
Thank you.
operator
Thank you. The next question comes from the line of Siddhan Kanodia from Tusk Investment. Please go.
Siddhant Kanodia
Yeah. Hi sir. So my first question is regarding the riper. You mentioned that the EBITDA loss for this quarter was 2.5. So what will be the nine months EBITDA loss? And are we expecting any EBITDA loss in Q4 as well?
Anurag Tantia
So nine months EBITDA loss is around 10 crores for Raipur. Yes. We do expect another one and a half to 2 crores of EBITDA loss in Q4.
Siddhant Kanodia
Okay. So full year we are expecting 12cr and so this number in next year, this will be a break even or can we expect some EBITDA positive.
Anurag Tantia
We hope to break even on a monthly basis in the next six months. So hopefully in the entire full financial year we should be just about EBITDA positive.
Siddhant Kanodia
Okay. And so my last question is regarding Jamshedpur next year. What. What sort of EBITDA loss are we expecting from that unit? And if we remove the Raipur facility, the nine month sales growth for the old center has been close to 7%. So going forward, should we take this as a base case or are we looking to improve?
Anurag Tantia
So the Jamshedpur facility is expected to be commissioned around Q4 of FY27. We expect losses of around 3 to 4 crores for that during the period. In terms of the growth in the current nine months or quarter, on quarter we’ve seen almost 10% or 11% growth from the existing four hospitals and a 7.5% growth from the Raipur hospital. We expect this traction to continue going forward as well.
Siddhant Kanodia
Okay, thank you sir. I’ll get back in the queue.
Anurag Tantia
Thank you.
operator
Thank you. A request to all participants, please restrict your questions to two for participants. For more questions please rejoin the queue. The next question comes from the line of Richard Chaudhary from Electrum pms. Please go ahead.
Richa Chaudhary
Hello. Yeah hi. Morning sir. I just had a couple of questions. So one on the is Salt Lake Hospital. So we had previously seen that the occupancy was roughly around 70% and plus but it has currently dropped to roughly around 60. So how that, how do we see that increase and back to 70 plus levels and similarly for the Dum Dum hospital also and all. And the second question is that right now we are roughly at around 700 beds and we are adding 150 beds Jamshedkur by Q4 of FY27. But in the Presentation. We have mentioned that we will reach 1000 beds hospital by FY27. So how do we see that happening?
Anurag Tantia
So with regards to Sol Lake, a key reason for the decrease in overall occupancy levels is the throughput having increased. If you look at it from a patient number perspective, our patient numbers are same if not growing. The reason bed occupancy has fallen is because the average length of stay has come down significantly. Significantly from almost 3.3 to 2.7 2.8. This is making more beds available which we are moving towards filling up and increasing productivity, which has already started happening in this financial year itself. The same applies to Dumdam as well. Dum Dum. There has been a significant reduction in the length of stay from almost 5 to 4.4 in the current quarter.
There is a strong focus on that hospital to restructure the number of departments and the type of departments. We have there to focus on high rpob, low state departments. This has already commenced with the starting of cardiac surgeries in Dumdam and there are more departments to be added in the flow. I’m sorry, what was the next question?
Richa Chaudhary
So we are currently at around 700 beds right now and we are adding jumps for that gap of region thousand by 2027.
Anurag Tantia
We are actively pursuing and evaluating opportunities which come to us. It is about a matter of time as to what ends up being the right foot for the expansion process.
Richa Chaudhary
Okay, thank you.
Anurag Tantia
Thank you.
operator
Thank you. The next question comes from the line of Vidisha from Pr Kotari. Please go ahead.
Anurag Tantia
I’m sorry, you’re not audible. You’re not audible.
operator
Ma’, am, we are unable to hear you.
Unidentified Participant
I don’t know. Yeah. So the only reason for DUM hospital occupancy going down is due to decrease in AMB length of stay or is there any other demand issue also?
Anurag Tantia
So it is a combination of reduction in average length of stay and as well as our focus on restructuring the number of departments and type of departments we have there. We are working strategically to reduce dependence on a couple of departments because of which we have been activating newer high rpob, low length of state departments which is causing this change to happen. We are well into the strategic change for almost nine months and we are seeing results of that starting to come in now.
Unidentified Participant
Okay, and any guidance on the revenue or the average revenue per bed?
Anurag Tantia
The average revenue per operating bed at Dum Dum is at around the 42,000 mark, which has increased from 40,000 from the previous quarter.
Unidentified Participant
Yeah, sir. I mean on the overall slide.
operator
We request you to return the question for the follow up question. Thank you. The next question comes from the line of Arpit the party from ig. Please go ahead.
Arpit Tapadia
Yeah, hi. Thank you for the opportunity. My question is regarding the occupancy rate. So how do the companies see the occupancy rate in next, let’s say medium term, let’s say two years.
Anurag Tantia
So we see the ideal occupancy rate should be at around the 70 to 75% mark depending on the size of the hospital. Most of our mature assets of Dum Dum and Salt Lake are around that mark. We expect the assets of Agarthalla and Havra to move around that mark in the next one year. Raipur being a new asset, we expect that it will be moving towards a 70% occupancy in the next in close to the next three years.
Arpit Tapadia
Okay, and what is the company’s strategy to increase the occupancy rate?
Anurag Tantia
We have been working across all hospitals on different departments. As I said, we’ve started oncology in the Agarthala hospital which is a comprehensive oncology care. That itself has started giving us a lot of traction. In the Saleh hospital we have been focusing a lot on gastroenterology and now with that we are starting GI surgeries as well. At Dum Dum we’ve added short IRPOP departments like cardiac surgery, xerology, interventional, cardiology. So like this, across all hospitals there is a lot of department focus which is starting to pay out dividends to us now.
Arpit Tapadia
Got it. And since having said that, we are going towards 1000 bedded capacity. So the next 300 odd beds would be a greenfield or are you looking for some amenities?
Anurag Tantia
So we’ve all towards the next 300 beds. We’ve already announced these Jamshedpur Hospital which should be starting within one year. That will be around 150 beds. Apart from that, we are looking out for options in the eastern part of the country. They may be Brownfield or Greenfield in nature.
Arpit Tapadia
Okay, thank you.
operator
Thank you. The next question comes from the line of Avinashwala from Sema India Private limited. Please go ahead.
Unidentified Participant
A couple of questions. The first question is on the existing hospital where you had mentioned earlier that both Agar Kala and Aura will move to the 70 occupancy but in one year.
Anurag Tantia
Yes, we are seeing significant traction for it to culminate in the next one to one and a half years. We have started quite a few departments. As we said, we started the oncology services in Agartala we started cardiac surgery in Agathalla. In Havada, we started robotic orthopedic surgeries and we’ve recently commissioned neurosurgeries as well. So there are quite a few departments which have been added in these hospitals for us to transition to that area.
Because Hara has been at 40%, it’s almost like doubling the occupancy. Just wanted to kind of. So havra we. As I said, there has been a lot of work going on in that region. We’ve changed the clinical mix, we’ve changed the departmental mix and that is starting to give us the results now.
Unidentified Participant
And the second question is, has the capex for the Jamshador been completely sprint?
Anurag Tantia
No, the Jamshedpur capex is about to start right now. The scope of work is to the developer post which our capex is going to start.
Unidentified Participant
Okay, so the 75 crores which the company has been spent.
Anurag Tantia
No, it has not been spent.
Unidentified Participant
Okay. Thank you.
operator
Thank you. The next question comes from the line of Ruchita from CJW Investments. Please go ahead.
Rucheeta Kadge
Hello, sir. A very good morning. My question was mainly regarding the occupancy rates only. So if you could just reiterate again in Agarkala, what is our in each of the hospitals? Basically, what is the target occupancy that we are looking at?
Anurag Tantia
See, the ideal occupancy is around the 70% mark across assets plus minus 5% depending on the size of assets. For Agarthala, we ideally expect the hospital to move to the 70% occupancy mark zone. For that we’ve started quite a few departments and are focusing on percolating those departments across the entire state of Tripur as well as eastern Bangladesh.
Rucheeta Kadge
Because it’s been at around 40, 45% since the last five years.
Anurag Tantia
It was around the 40%. It was at around the 40% mark. It has already moved to the 51, 52% mark and we’re seeing significant traction for it to go further up.
Rucheeta Kadge
Okay, and the RPOP there, what is the expectation?
Anurag Tantia
The RPOP in Agartala is at around the 37,000 mark while our network RPOP is around 39,000. We expect it to move towards the network RPAP or be around at a slight discount to the network considering its locational disadvantages.
Rucheeta Kadge
This is considering by FY30 or is this very near term that you’re talking about?
Anurag Tantia
Sorry, it was not audible. The question was not audible.
Rucheeta Kadge
Yeah, I’m saying that. Are you expecting this by FY30 like in the next 4, 5 years? Are you expecting this immediately in the medium term, let’s say by.
Anurag Tantia
We are already at the 37,000 mark at an RPOB level and our network is at the 39,600. We expect regular inflationary growth to happen to this.
Rucheeta Kadge
Okay. And what about Dum Dum hospital? What is the kind of occupancy?
Anurag Tantia
Dum Dum is at almost the 65, 66% mark. And as I said there have been significant changes in the departments there. Also we are seeing. We are hopeful that it should be moving towards the optimal occupancy sooner. Correct.
Rucheeta Kadge
Okay. And Havra also because around 40, 45%.
Anurag Tantia
As I said previously also we have already activated quite a few new departments in Havra including interventional cardiology, Robotic surgery and orthopedics. And it has started giving us traction. The occupancy has moved up by almost 5 percentage points in the past six months. And we expect it to go up further as we are further strengthening these departments.
Rucheeta Kadge
But this 70% mark, by which year do we.
Anurag Tantia
Should be reaching the 70% in the next one and a half years in.
Rucheeta Kadge
All the mature hospitals, right?
Anurag Tantia
Yes, that is the target.
Rucheeta Kadge
Okay, thank you so much.
operator
Thank you. The next question comes from the line of Vidisha from Pr. Kothari Sons. Please go ahead. You may proceed with your question. As there is no response from the current participant, we move towards the next question. The next question comes from the line of Anuj Kashyap from A3 Capital. Please go ahead.
Anuj Kashyap
Good morning. I’m audible. Yes, please go ahead. I wanted to know, is there any. Good strategy to attract the central government employees? As the central government has revised its remuneration for the insurance health insurance for its employees.
Anurag Tantia
So we do take CGHS patients in some of our hospitals depending on the occupancy levels. At this point we are taking CGHS patients in Agarthal Hospital. And we are looking at extending that facility into the newly commissioned Tripur hospital.
Anuj Kashyap
Will that be margin accretive for us?
Anurag Tantia
Definitely. With the welcome move of increase in tariff in the CGHS rates, it should contribute to the overall profitability of the hospital. At this point, with the volume being very low for us, it is difficult to quantify how much margin accretive it will be. But it should definitely be an improvement. And one last one, sir.
Anuj Kashyap
So like in presentation you have mentioned the eastern region. Like strategically like Bihar, UP and Odisha. You want to target the tire two tier three cities. So sir, will that be organic or inorganic?
Anurag Tantia
So we have already announced the hospital in Jamshedpur which will be commissioned in the next one year. Apart from that we are looking at inorganic opportunities in these locations. However, if there was organic opportunity and the city was very attractive, we would be open to that as well.
Anuj Kashyap
That would be best to understand the features.
operator
Thank you ladies and gentlemen. That was the last question for today. I now hand the conference over to the management for closing comments. Thank you. And over to you sir.
Anurag Tantia
Thank you everyone for your questions which I hope we’ve suitably addressed. In case you have any further queries, please do get in touch with us. Thank you for your continued support and trust in our company’s vision and capabilities. Together we look forward to achieving new milestones and creating lasting value. Thank you and have a good day ahead.
operator
Thank you. On behalf of GPT Healthcare limited that concludes this conference. Thank you for joining us and you may now disconnect your line. Thank you.